This statistic shows the sales value of the ten most prescribed medications for benign prostatic hyperplasia (BPH) in South Korea in 2016. During the measured year, the prescription sales of Harnal, manufactured by Astellas, amounted to around 41.78 million U.S. dollars in South Korea.
Sales value of the 10 most prescribed medications for benign prostatic hyperplasia (BPH) in South Korea in 2016
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
KHIDI. (February 6, 2018). Sales value of the 10 most prescribed medications for benign prostatic hyperplasia (BPH) in South Korea in 2016 (in million U.S. dollars) [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/863815/south-korea-prostatic-hyperplasia-most-prescribed-medications-sales-value/
KHIDI. "Sales value of the 10 most prescribed medications for benign prostatic hyperplasia (BPH) in South Korea in 2016 (in million U.S. dollars)." Chart. February 6, 2018. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/863815/south-korea-prostatic-hyperplasia-most-prescribed-medications-sales-value/
KHIDI. (2018). Sales value of the 10 most prescribed medications for benign prostatic hyperplasia (BPH) in South Korea in 2016 (in million U.S. dollars). Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/863815/south-korea-prostatic-hyperplasia-most-prescribed-medications-sales-value/
KHIDI. "Sales Value of The 10 Most Prescribed Medications for Benign Prostatic Hyperplasia (Bph) in South Korea in 2016 (in Million U.S. Dollars)." Statista, Statista Inc., 6 Feb 2018, https://www-statista-com.ezproxy.canberra.edu.au/statistics/863815/south-korea-prostatic-hyperplasia-most-prescribed-medications-sales-value/
KHIDI, Sales value of the 10 most prescribed medications for benign prostatic hyperplasia (BPH) in South Korea in 2016 (in million U.S. dollars) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/863815/south-korea-prostatic-hyperplasia-most-prescribed-medications-sales-value/ (last visited November 10, 2024)
Sales value of the 10 most prescribed medications for benign prostatic hyperplasia (BPH) in South Korea in 2016 (in million U.S. dollars) [Graph], KHIDI, February 6, 2018. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/863815/south-korea-prostatic-hyperplasia-most-prescribed-medications-sales-value/
